Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67076 - 67100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	GPD1L	23171	downregulated	rosiglitazone results in decreased expression of GPD1L mRNA	3p22.3	A10216
Rosiglitazone	Approved Investigational	GPER1	2852	downregulated	rosiglitazone results in decreased expression of GPER1 mRNA	7p22.3	A22609
Rosiglitazone	Approved Investigational	GPT	2875	downregulated	rosiglitazone results in decreased expression of GPT mRNA	8q24.3	A22609
Rosiglitazone	Approved Investigational	GSN	2934	upregulated	rosiglitazone results in increased expression of GSN mRNA	9q33.2	A20877
Rosiglitazone	Approved Investigational	GUSB	2990	upregulated	rosiglitazone results in increased expression of GUSB mRNA	7q11.21	A10216
Rosiglitazone	Approved Investigational	GYPC	2995	upregulated	rosiglitazone results in increased expression of GYPC mRNA	2q14.3	A22609
Rosiglitazone	Approved Investigational	HADHB	3032	upregulated	rosiglitazone results in increased expression of HADHB mRNA	2p23.3	A22609
Rosiglitazone	Approved Investigational	HAGH	3029	downregulated	rosiglitazone results in decreased expression of HAGH mRNA	16p13.3	A22609
Rosiglitazone	Approved Investigational	HFE2	148738	downregulated	rosiglitazone results in decreased expression of HFE2 mRNA	1q21.1	A22609
Rosiglitazone	Approved Investigational	HIPK2	28996	upregulated	rosiglitazone results in increased expression of HIPK2 mRNA	7q34	A10216
Rosiglitazone	Approved Investigational	HIST1H2BD	3017	downregulated	rosiglitazone results in decreased expression of HIST1H2BD mRNA	6p22.2	A10216
Rosiglitazone	Approved Investigational	HK2	3099	upregulated	rosiglitazone results in increased expression of HK2 mRNA	2p12	A24109
Rosiglitazone	Approved Investigational	HLA-DRA	3122	downregulated	rosiglitazone results in decreased expression of HLA-DRA mRNA	6p21.32	A22609
Rosiglitazone	Approved Investigational	HLX	3142	downregulated	rosiglitazone results in decreased expression of HLX mRNA	1q41	A10216
Rosiglitazone	Approved Investigational	HMOX1	3162	upregulated	rosiglitazone results in increased expression of HMOX1 mRNA	22q12.3	A24118
Rosiglitazone	Approved Investigational	HPN	3249	downregulated	rosiglitazone results in decreased expression of HPN mRNA	19q13.11	A22609
Rosiglitazone	Approved Investigational	HSD11B1	3290	downregulated	rosiglitazone results in decreased expression of HSD11B1 mRNA	1q32.2	A23178 A24119
Rosiglitazone	Approved Investigational	HSPA5	3309	upregulated	rosiglitazone results in increased expression of HSPA5 mRNA	9q33.3	A24120
Rosiglitazone	Approved Investigational	HTR3A	3359	upregulated	rosiglitazone results in increased expression of HTR3A mRNA	11q23.2	A22609
Rosiglitazone	Approved Investigational	IARS	3376	upregulated	rosiglitazone results in increased expression of IARS mRNA	9q22.31	A22609
Rosiglitazone	Approved Investigational	ICAM1	3383	downregulated	rosiglitazone results in decreased expression of ICAM1 mRNA	19p13.2	A24121
Rosiglitazone	Approved Investigational	IGFBP2	3485	downregulated	rosiglitazone results in decreased expression of IGFBP2 mRNA	2q35	A22609
Rosiglitazone	Approved Investigational	IL1R1	3554	downregulated	rosiglitazone results in decreased expression of IL1R1 mRNA	2q11.2-q12.1	A10216
Rosiglitazone	Approved Investigational	IL1RAP	3556	downregulated	rosiglitazone results in decreased expression of IL1RAP mRNA	3q28	A10216
Rosiglitazone	Approved Investigational	IL22RA1	58985	downregulated	rosiglitazone results in decreased expression of IL22RA1 mRNA	1p36.11	A22609

Displaying entries 67076 - 67100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability